Previous 10 | Next 10 |
The company is awaiting a decision from the ITC concerning the use of Jeuveau in the US. Implied volatility is well over 240%. The stock is dirt-cheap if the ban is not inflicted. Risk is high, however, so we are leaning towards a volatility play instead of a directional one. ...
NEW YORK, NY / ACCESSWIRE / November 20, 2020 / Cohen Milstein Sellers & Toll PLLC is investigating Evolus, Inc. (NASDAQ:EOLS) ("Evolus" or the "Company") following the filing of a class action lawsuit alleging violations of federal securities law. If you purchased Evolus shares betwe...
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Evolus To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - November 11, 2020) - If you suffered losses exceeding $100,000 investing in Evolus sto...
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Evolus To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - November 4, 2020) - If you suffered losses exceeding $100,000 investing in Evolus stock or o...
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Evolus To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - November 1, 2020) - If you suffered losses exceeding $100,000 investing in Evolus stock or o...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
NEWPORT BEACH, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced the promotion of two members of its Leadership Team. Michael Mazen Jafar has...
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Evolus To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - October 20, 2020) - If you suffered losses exceeding $100,000 investing in Evolus stock or o...
NEW YORK, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Evolus, Inc. (“Evolus” or the “Company”) (NASDAQ: EOLS) in the United States District Court for the Southern District of New Yor...
New York, New York--(Newsfile Corp. - September 11, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Evolus, Inc. ("Evolus" or the "Company") (NASDAQ: EOLS). If you invested in Evolus stock or options and would like to d...
News, Short Squeeze, Breakout and More Instantly...
Total Net Revenue of $66.9 Million for Q2 2024, Up 36% from Q2 2023 Raises Full-Year 2024 Net Revenue Guidance to $260 Million to $270 Million, Representing Year-Over-Year Growth of 34% at the Top End Improved Quarterly GAAP Operating Loss to $7.7 Million; Delivered First Ever Qua...
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will host an Investor Day on Thursday, September 12, 2024 in New York City. Attendees can join in-person or participate via webcast. The even...
Launching into this growth market 1 as part of the company’s geographic expansion strategy Evolus Australia established to drive medical education, training, marketing and sales to medical aesthetics healthcare professionals Evolus, Inc. (NASDAQ: EOLS), a perf...